As the pages of the past year turn, we find ourselves immersed in a tapestry of extraordinary accomplishments that have shaped Ligence’s trajectory. Each milestone is a testament to our unwavering dedication, a reminder of the strides we’ve made in reshaping healthcare through innovation. Join us on this introspective voyage, as we retrace the path of our notable achievements in the precise order they unfolded.
Automa+ in Zürich, Switzerland: Bridging Boundaries
Our year began in the picturesque landscapes of Zürich, Switzerland, as Ligence participated in #Automa+. Upon reflection, this event served as a bridge, uniting our commitment to technological advancement and the collective drive for progress in the medical field. Looking back, it was the spark that ignited the journey we embarked upon.
BSEcho2022: Crafting Excellence
As we delve into the annals of the past year, the memory of BSEcho2022 stands out prominently. The event served as a canvas where we painted a portrait of excellence. It was here that we unveiled the newest strain release, an embodiment of our ceaseless pursuit of perfection and innovation.
Radiological Society of North America (RSNA) 2022: A Glowing Presence
The radiance of our presence at the Radiological Society of North America (RSNA) 2022 annual meeting continues to illuminate our reflections. Looking back, this event marked the initial step in embedding advanced technology seamlessly within the healthcare domain. It was the beginning of a journey that would redefine medical possibilities.
ESCardioAsia 2022: Lighting Up Singapore
In the vibrant city of Singapore, Ligence illuminated the stage at #ESCardioAsia 2022. The significance of this moment crystallizes as we retrospectively recognize it as the platform where the Ligence Heart system was first showcased. This event symbolized the fusion of technological brilliance and medical expertise that would set the tone for the year.
Arab Health Exhibition 2023: Dubai Dreams
As we cast our minds back to the dawn of the year, the Arab Health Exhibition in Dubai stands as a vivid memory. It was here that we represented Ligence with pride, embracing the dream of transforming healthcare through pioneering technology. In hindsight, this event was a cornerstone of our year of accomplishments.
Embracing New Orleans and ACC2023
The soulful rhythms of New Orleans beckoned us to #ACC2023, where Ligence’s impact resonated deeply. As we look back, we realize that this journey not only embraced the blues but also introduced our state-of-the-art automated echocardiographic analysis software. This convergence of music, medicine, and innovation painted the backdrop of a remarkable year.
EACVI Congress 2023: Barcelona Bound
The journey of retrospection takes us to the #EACVI Congress 2023, where Ligence’s presence was felt in the heart of Barcelona. Looking back, this event encapsulated the convergence of technology and healthcare, setting the stage for the remarkable advancements that would unfold throughout the year.
Heart Failure 2023: A Journey of Progress
As we close the chapter of retrospection, the Heart Failure 2023 conference in Prague stands as a beacon of progress. In the rearview mirror, this event takes on new significance, representing a journey into the realms of preventing, diagnosing, and treating heart failure. It was a testament to our unyielding commitment to the betterment of healthcare.
This retrospective voyage through time encapsulates the essence of Ligence’s journey over the past year – a relentless pursuit of innovation, a dedication to excellence, and an unbreakable bond with the future of healthcare. As we stride into the unknown of the upcoming year, we carry these reflections with us, driving us forward to new horizons and greater achievements.
Ligence Heart app development is co-funded by European Union – project “AI-driven cardiac ultrasound analysis”.
Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
